BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 17379526)

  • 1. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
    Takano Y; Hase-Aoki K; Horiuchi H; Zhao L; Kasahara Y; Kondo S; Becker MA
    Life Sci; 2005 Mar; 76(16):1835-47. PubMed ID: 15698861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives.
    Sathisha KR; Khanum SA; Chandra JN; Ayisha F; Balaji S; Marathe GK; Gopal S; Rangappa KS
    Bioorg Med Chem; 2011 Jan; 19(1):211-20. PubMed ID: 21163661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb.
    Umamaheswari M; Asokkumar K; Sivashanmugam AT; Remyaraju A; Subhadradevi V; Ravi TK
    J Ethnopharmacol; 2009 Jul; 124(3):646-8. PubMed ID: 19467311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of xanthine oxidase by benzothiazinone analogues.
    Sheu SY; Lin CY; Wu JD; Chiang HC
    Anticancer Res; 1999; 19(1A):119-23. PubMed ID: 10226532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
    Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL
    Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzophenones as xanthine oxidase inhibitors.
    Sheu SY; Tsai HJ; Chiang HC
    Anticancer Res; 1999; 19(2A):1131-5. PubMed ID: 10368664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers.
    Unno T; Sugimoto A; Kakuda T
    J Ethnopharmacol; 2004 Aug; 93(2-3):391-5. PubMed ID: 15234783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olea europaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase.
    Flemmig J; Kuchta K; Arnhold J; Rauwald HW
    Phytomedicine; 2011 May; 18(7):561-6. PubMed ID: 21144719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.
    You ZL; Shi DH; Xu C; Zhang Q; Zhu HL
    Eur J Med Chem; 2008 Apr; 43(4):862-71. PubMed ID: 17706325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase.
    Naoghare PK; Kwon HT; Song JM
    J Pharm Biomed Anal; 2010 Jan; 51(1):1-6. PubMed ID: 19679420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-(N-benzoylamino)purine as a novel and potent inhibitor of xanthine oxidase: inhibition mechanism and molecular modeling studies.
    Tamta H; Thilagavathi R; Chakraborti AK; Mukhopadhyay AK
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):317-24. PubMed ID: 16206825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of xanthine oxidase by cytokinins and related substances.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1996; 16(6B):3571-6. PubMed ID: 9042223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibitors from Brandisia hancei.
    Kong LD; Wolfender JL; Cheng CH; Hostettmann K; Tan RX
    Planta Med; 1999 Dec; 65(8):744-6. PubMed ID: 10630118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
    Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L
    Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.
    Hu L; Hu H; Wu W; Chai X; Luo J; Wu Q
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4013-5. PubMed ID: 21620698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
    Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
    Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of pyrazolo[3,4-d]thiazolo[3,2-a]pyrimidin-4-one derivatives: in silico approach.
    Khobragade CN; Bodade RG; Dawane BS; Konda SG; Khandare NT
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):615-21. PubMed ID: 20001274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.